GoldenGolden
Casdin Capital

Casdin Capital

Casdin Capital, LLC is an investment firm focused on disruptive businesses in the life sciences and healthcare industry.

Casdin Capital is an investment firm founded in 2011. The firm is headquartered in New York City, United States. Casdin Capital specializes in funding companies in the life sciences, biotechnology and healthcare sectors. The firm provides capital for companies from the early to late stages of development. As of December 2019, Casdin Capital is managing a portfolio of 32 active companies and has sold off its stakes in 21 companies.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Andrea Park
June 8, 2021
FierceBiotech
The at-home diagnostics provider closed its high-flying series D with support from a handful of longtime backers that included Illumina Ventures, UnitedHealth's Optum Ventures and golfer Rory McIlroy, through his own Symphony Ventures.
Andrea Park
April 16, 2021
FierceBiotech
C2i Genomics, which is developing a blood test to detect residual cancer cells after tumor removal, just closed $100 million in new funding, nearly 10 times the size of the series A it racked up less than a year ago.
April 15, 2021
WebWire
C2i Genomics, a cancer intelligence company, today announced $100 million in financing led by Casdin Capital with participation from NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. The funding will accelerate clinical development and commercialization of the company's C2-Intelligence Platform, a cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease that is up...
BioSpace
April 9, 2021
BioSpace
CM Life Sciences III Inc. (the " Company ") announced today that it closed its initial public offering of 55,200,000 units at $10.00 per unit, including 7,200,000 units issued pursuant to the exercise in full by the underwriters of its over-allotment option.
Heather Landi
April 5, 2021
FierceHealthcare
Cleo Health hauled in $40 million to scale up its family benefits platform for working parents and families, BrightInsight banked $101 million to grow its digital health platform for biopharma and medtech companies and more funding news in March.
Heather Landi
March 24, 2021
FierceHealthcare
Healthcare "map maker" Komodo Health netted $220 million in new funding to build out its data analytics platform for life sciences research. The startup has created a massive "healthcare map," an artificial intelligence platform that compiles de-identified healthcare data from hundreds of sources and more than 325 million individual patients.
Conor Hale
January 14, 2021
FierceBiotech
After scoring two European approvals last month for its artificial-intelligence-powered cancer pathology platforms, Paige has secured $100 million in new funding to boost its development of biomarkers as clinical applications.
BioSpace
December 1, 2020
BioSpace
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced two new co-investments with innovation accelerator partner Casdin Capital.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.